Results 31 to 40 of about 245,839 (304)

10 year anniversary of the journal Apstract: the history of an open access journal [PDF]

open access: yes, 2017
The idea initiating the birth of the journal APSTRACT was initiated by András Nábrádi, during a 2005 AGRIMBA1 executive board meeting held in Aberdeen, UK.
Csapó, Zsolt   +3 more
core   +3 more sources

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Le Calmar opte pour son encre. Aperçu contingent. Case Study sur l'Université de Zagreb [PDF]

open access: yesMeta: Research in Hermeneutics, Phenomenology and Practical Philosophy, 2016
The Squid opts for ist own Ink: Case study on Zagreb University The article discusses the implications of the student revolt in 2009 at the Zagreb University in the context of the idea of university (universitas), the idea of knowledge and the idea of
Nenad Ivić
doaj  

Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch-Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives

open access: yesPediatric Health, Medicine and Therapeutics, 2023
Mario Sestan, Marija Jelusic Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, CroatiaCorrespondence: Marija Jelusic, University of Zagreb School of Medicine, University Hospital Centre Zagreb,
Sestan M, Jelusic M
doaj  

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić   +4 more
wiley   +1 more source

“Influence of Clinically Active Graves’ Ophthalmopathy on Spherical Equivalent and Visual Acuity”

open access: yesClinical Ophthalmology, 2022
Jasenka Petrovic Jurcevic,1 Marko Jurcevic,2 Mateja Jagic,3 Anamarija Jazbec,4 Kresimir Mandic,5 Jelena Juri Mandic5 1Medical School University of Zagreb, PhD Candidate on the Programme “Biomedicine and Health”, Zagreb, Croatia; 2University of Zagreb ...
Petrovic Jurcevic J   +5 more
doaj  

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang   +12 more
wiley   +1 more source

László Podolszki, PhD in Technical Sciences

open access: yesKartografija i Geoinformacije, 2015
László Podolszki defended his doctoral thesis Stereoscopic analysis of landslides and landslide susceptibility on the southern slopes of the Medvednica Mt.
Snježana Mihalić Arbanas
doaj  

Ressenyes [PDF]

open access: yes, 2002
Obra ressenyada: Histria Antiqua [revista]. Pula: University of Zagreb, International Centre of Croatian Universities in Istria; International Research Centre for Archaeology, Brijuni ...
Gutiérrez García-Moreno, Anna
core  

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy